Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
暂无分享，去创建一个
I. Flinn | R. Larson | R. Clark | H. Kantarjian | G. Saglio | M. Kurokawa | A. Hochhaus | T. Hughes | N. Gallagher | R. Blakesley | D-W. Kim | G. Étienne | R. Yu | B. Moiraghi | D. Kim | T. Hughes